The articles in the Vaccinations and Women’s Reproductive Health special section highlight the importance of access to safe and effective vaccines to reduce morbidity and mortality among women, particularly in low- and middle- income countries. 

Most vaccination programmes specifically target infants and young children; however, there has been a recent increase in use of vaccines in adolescents and adults, especially in women.

In October 2021, the FIGO Women’s Cancer Committee established the Endometrial Cancer Staging subcommittee to review new and established findings on endometrial cancer treatment, prognosis, and survival.

In addition to attending the XXIV FIGO World Congress of Gynecology and Obstetrics, the Fellowship will provide an opportunity to attend a centre of excellence in gynaecologic oncology in Paris on 2–6 October 2023, to gain clinical and research experience.

This workshop aims to identify specific barriers to the implementation of current World Health Organization (WHO) guidelines on vaccination programmes for women, including the WHO 2020 Global Strategy for the Elimination of Cervical Cancer.  

For World Cancer Day 2022, we are spotlighting FIGO’s Pilot Project to Eliminate Cervical Cancer, and the recently launched pilot grants which, in partnership with FIGO’s Member Societies, are taking essential steps on the path towards the global elimination of cervical cancer.   

The five successful applications to the pilot project came from the Colombian Federation of Obstetrics and Gynecology (FECOLSOG), the Bengal Obstetric and Gynecological Society (BOGS), the Federation of Obstetric and Gynaecological Societies of India (FOGSI), the Nepal Society of Obstetricians and Gynaecologists (NESOG) and the End Cervical Cancer Nigeria Initiative (ECCNI).

Across the globe, human papillomavirus (HPV) vaccination and cervical cancer screening programmes are not being implemented to their maximum potential to prevent and eliminate cervical cancer. However, some promising progress has been made since the development of the World Health Organization (WHO) 90-70-90 Strategy in 2018.

The WHO 90-70-90 Strategy

In 2018, the WHO developed its global strategy to accelerate the elimination of cervical cancer as a public health problem.